Cargando…

A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age

Urinary tract infections (UTIs) are a common reason for hospitalization in infants younger than 60 days, and the optimal approach to intravenous (IV) antibiotic therapy upon UTI diagnosis in this cohort is unknown. We determined whether there was an association between IV antibiotic therapy duration...

Descripción completa

Detalles Bibliográficos
Autores principales: Zu’bi, Fadi, Pokarowski, Martha, Al-Kutbi, Rusul, Science, Michelle, Vallipuram, Janaki, O’Kelly, Fardod, Chua, Michael, Friedman, Jeremy, Koyle, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478320/
https://www.ncbi.nlm.nih.gov/pubmed/36803102
http://dx.doi.org/10.1177/00099228231154364
_version_ 1785101323207704576
author Zu’bi, Fadi
Pokarowski, Martha
Al-Kutbi, Rusul
Science, Michelle
Vallipuram, Janaki
O’Kelly, Fardod
Chua, Michael
Friedman, Jeremy
Koyle, Martin
author_facet Zu’bi, Fadi
Pokarowski, Martha
Al-Kutbi, Rusul
Science, Michelle
Vallipuram, Janaki
O’Kelly, Fardod
Chua, Michael
Friedman, Jeremy
Koyle, Martin
author_sort Zu’bi, Fadi
collection PubMed
description Urinary tract infections (UTIs) are a common reason for hospitalization in infants younger than 60 days, and the optimal approach to intravenous (IV) antibiotic therapy upon UTI diagnosis in this cohort is unknown. We determined whether there was an association between IV antibiotic therapy duration (long [>3 days] vs short [≤3 days]) and treatment failure via a retrospective review of infants with confirmed UTIs receiving IV antibiotics at a tertiary referral center. A total of 403 infants were included; 39% were treated with ampicillin and cefotaxime, and 34% with ampicillin and gentamycin or tobramycin. The median IV antibiotic duration was 5 (interquartile range: 3-10) days, and 5% of patients experienced treatment failure. The treatment failure rate was similar in both short- and long-course IV antibiotic groups (P > .05), and there was no significant association between treatment duration and failure. We conclude that treatment failure for infants hospitalized with UTI is uncommon and not associated with IV antibiotic duration.
format Online
Article
Text
id pubmed-10478320
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-104783202023-09-06 A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age Zu’bi, Fadi Pokarowski, Martha Al-Kutbi, Rusul Science, Michelle Vallipuram, Janaki O’Kelly, Fardod Chua, Michael Friedman, Jeremy Koyle, Martin Clin Pediatr (Phila) Articles Urinary tract infections (UTIs) are a common reason for hospitalization in infants younger than 60 days, and the optimal approach to intravenous (IV) antibiotic therapy upon UTI diagnosis in this cohort is unknown. We determined whether there was an association between IV antibiotic therapy duration (long [>3 days] vs short [≤3 days]) and treatment failure via a retrospective review of infants with confirmed UTIs receiving IV antibiotics at a tertiary referral center. A total of 403 infants were included; 39% were treated with ampicillin and cefotaxime, and 34% with ampicillin and gentamycin or tobramycin. The median IV antibiotic duration was 5 (interquartile range: 3-10) days, and 5% of patients experienced treatment failure. The treatment failure rate was similar in both short- and long-course IV antibiotic groups (P > .05), and there was no significant association between treatment duration and failure. We conclude that treatment failure for infants hospitalized with UTI is uncommon and not associated with IV antibiotic duration. SAGE Publications 2023-02-21 2023-10 /pmc/articles/PMC10478320/ /pubmed/36803102 http://dx.doi.org/10.1177/00099228231154364 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Articles
Zu’bi, Fadi
Pokarowski, Martha
Al-Kutbi, Rusul
Science, Michelle
Vallipuram, Janaki
O’Kelly, Fardod
Chua, Michael
Friedman, Jeremy
Koyle, Martin
A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age
title A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age
title_full A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age
title_fullStr A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age
title_full_unstemmed A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age
title_short A Comparison of Short Versus Long Course Intravenous Antibiotics When Treating Urinary Tract Infection in Infants <60 Days of Age
title_sort comparison of short versus long course intravenous antibiotics when treating urinary tract infection in infants <60 days of age
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478320/
https://www.ncbi.nlm.nih.gov/pubmed/36803102
http://dx.doi.org/10.1177/00099228231154364
work_keys_str_mv AT zubifadi acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT pokarowskimartha acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT alkutbirusul acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT sciencemichelle acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT vallipuramjanaki acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT okellyfardod acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT chuamichael acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT friedmanjeremy acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT koylemartin acomparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT zubifadi comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT pokarowskimartha comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT alkutbirusul comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT sciencemichelle comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT vallipuramjanaki comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT okellyfardod comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT chuamichael comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT friedmanjeremy comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage
AT koylemartin comparisonofshortversuslongcourseintravenousantibioticswhentreatingurinarytractinfectionininfants60daysofage